Table 2.
Comparison of PSA Levels by Age in Group A Versus Group B
| Group A | |||||
| Age (y) | n | PSA < 4 ng/mL (%) | PSA 4–9.99 ng/mL (%) | PSA ≥ 10 (%) | |
| < 55 | 36 | 5 (13.9) | 25 (66.7) | 6 (19.4) | |
| 56–69 | 226 | 23 (10.2) | 150 (64.6) | 53 (25.2) | |
| 70–80 | 140 | 17 (12.1) | 80 (56.4) | 43 (31.4) | |
| 402 | 45 (11.1) | 255 (63.4) | 102 (25.4) | ||
| Group B | |||||
| Age (y) | n | PSA < 4 ng/mL (%) | PSA 4–9.99 ng/mL (%) | PSA ≥ 10 (%) | P Valuea |
| < 55 | 43 | 5 (12) | 27 (63) | 11 (25.6) | .6267 |
| 56–69 | 179 | 9 (5) | 129 (72) | 41 (22.9) | .1470 |
| 70–80 | 47 | 3 (6) | 28 (60) | 16 (34) | .5350 |
| 269 | 17 (6.7) | 184 (68.4) | 68 (25.2) | .0929 |
PSA, prostate-specific antigen.
aP = .0929 (no statistically significant difference in PSA for < 4 ng/mL, 4–10 ng/mL, or ≥ 10 ng/mL in Group A versus Group B for any age group).